Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cipla
Medtronic
US Army
Daiichi Sankyo
Dow
US Department of Justice
Boehringer Ingelheim
Teva

Generated: July 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040032

« Back to Dashboard

NDA 040032 describes CYCLOPHOSPHAMIDE, which is a drug marketed by Amerigen Pharms Ltd, Sti Pharma Llc, West-ward Pharms Int, Amneal Pharms Co, Baxter Hlthcare, Jiangsu Hengrui Med, and Roxane, and is included in eleven NDAs. It is available from seven suppliers. Additional details are available on the CYCLOPHOSPHAMIDE profile page.

The generic ingredient in CYCLOPHOSPHAMIDE is cyclophosphamide. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Summary for 040032
Tradename:CYCLOPHOSPHAMIDE
Applicant:Roxane
Ingredient:cyclophosphamide
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 040032
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYCLOPHOSPHAMIDE cyclophosphamide TABLET;ORAL 040032 ANDA Physicians Total Care, Inc. 54868-5005 E 54868-5005-0
CYCLOPHOSPHAMIDE cyclophosphamide TABLET;ORAL 040032 ANDA Physicians Total Care, Inc. 54868-5218 E 54868-5218-0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Aug 17, 1999TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Aug 17, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Queensland Health
Federal Trade Commission
Covington
Johnson and Johnson
Moodys
Fuji
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.